Tim Denison – a professor of engineering science at Oxford University and co-founder and chief engineer of London-based Amber Therapeutics, which developed the implant with the university – hopes the device will be available on the NHS in four to five years' time, and around the world.
The technology is part of a growing number of neural implants being developed to treat a wide range of conditions, including brain cancer, chronic pain, rheumatoid arthritis, Parkinson's, incontinence and tinnitus. These devices are more sophisticated than previous implants in that they do not just decode the brain's electrical activity, but regulate it. It is also a sector in which Europe is taking on the US in a race to develop the life-changing tech.
Member
